ARTICLE | Company News
NICE rebuffs Cell Therapeutics' Pixuvri
April 11, 2013 12:34 AM UTC
The U.K.'s NICE issued preliminary Pixuvri pixantrone from Cell Therapeutics Inc. (NASDAQ:CTIC; Milan:CTIC) to treat multiply relapsed or refractory aggressive non-Hodgkin's B cell lymphoma -- its app...